{"entity":{"type":"insider","cik":"0001674492","url":"/insider/0001674492","json_url":"/insider/0001674492.json","name":"Warbington Timothy","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":12,"first":"2016-11-14","last":"2023-06-29","span_basis":"filed_date"},"name_variants":[{"name":"Warbington Timothy","source":"filing","n_filings":12,"first_seen":"2016-11-14","last_seen":"2023-06-29"}],"transactions":[{"id":8496515,"accession":"0001477932-23-004914","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001477932-23-004914","line_url":"/filing/0001477932-23-004914#line-4","is_derivative":false,"issuer_cik":"0001187953","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001187953","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":4.36,"price_display":"4.36","price_state":"stated","total_value":872.0,"total_display":"872.00","total_whole":"872","shares_owned_after":12209.0,"shares_owned_after_display":"12,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-28","filed_date":"2023-06-29","scope":"insider"},{"id":8496511,"accession":"0001477932-23-004914","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001477932-23-004914","line_url":"/filing/0001477932-23-004914","is_derivative":false,"issuer_cik":"0001187953","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001187953","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":4.43875,"price_display":"4.44","price_state":"stated","total_value":3551.0,"total_display":"3,551.00","total_whole":"3,551","shares_owned_after":11809.0,"shares_owned_after_display":"11,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-27","filed_date":"2023-06-29","scope":"insider","n_lines":3},{"id":6391664,"accession":"0001477932-22-008858","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001477932-22-008858","line_url":"/filing/0001477932-22-008858","is_derivative":false,"issuer_cik":"0001187953","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001187953","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.389742,"price_display":"0.39","price_state":"stated","total_value":3897.42,"total_display":"3,897.42","total_whole":"3,897","shares_owned_after":111887.0,"shares_owned_after_display":"111,887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-22","filed_date":"2022-11-23","scope":"insider","n_lines":2},{"id":6391658,"accession":"0001477932-22-008858","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001477932-22-008858","line_url":"/filing/0001477932-22-008858","is_derivative":false,"issuer_cik":"0001187953","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001187953","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.39766666666666667,"price_display":"0.40","price_state":"stated","total_value":5965.0,"total_display":"5,965.00","total_whole":"5,965","shares_owned_after":97087.0,"shares_owned_after_display":"97,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-23","scope":"insider","n_lines":2},{"id":6949772,"accession":"0001477932-22-007299","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001477932-22-007299","line_url":"/filing/0001477932-22-007299#line-1","is_derivative":false,"issuer_cik":"0001187953","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001187953","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","total_whole":"10,000","shares_owned_after":87087.0,"shares_owned_after_display":"87,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-27","filed_date":"2022-09-28","scope":"insider"},{"id":6450719,"accession":"0001477932-22-007108","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001477932-22-007108","line_url":"/filing/0001477932-22-007108#line-5","is_derivative":false,"issuer_cik":"0001187953","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001187953","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":0.54,"price_display":"0.54","price_state":"stated","total_value":6480.0,"total_display":"6,480.00","total_whole":"6,480","shares_owned_after":67087.0,"shares_owned_after_display":"67,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-22","filed_date":"2022-09-22","scope":"insider"},{"id":6450716,"accession":"0001477932-22-007108","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001477932-22-007108","line_url":"/filing/0001477932-22-007108","is_derivative":false,"issuer_cik":"0001187953","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001187953","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":0.6112416666666667,"price_display":"0.61","price_state":"stated","total_value":18337.25,"total_display":"18,337.25","total_whole":"18,337","shares_owned_after":55087.0,"shares_owned_after_display":"55,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-21","filed_date":"2022-09-22","scope":"insider","n_lines":4},{"id":6370548,"accession":"0001477932-22-004177","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001477932-22-004177","line_url":"/filing/0001477932-22-004177","is_derivative":false,"issuer_cik":"0001187953","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001187953","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.91536,"price_display":"0.92","price_state":"stated","total_value":22884.0,"total_display":"22,884.00","total_whole":"22,884","shares_owned_after":25087.0,"shares_owned_after_display":"25,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-07","scope":"insider","n_lines":3},{"id":5227853,"accession":"0001441557-17-000032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441557-17-000032","line_url":"/filing/0001441557-17-000032#line-1","is_derivative":false,"issuer_cik":"0001187953","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001187953","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (CEO & President), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":1000.0,"total_display":"1,000.00","total_whole":"1,000","shares_owned_after":58655927.0,"shares_owned_after_display":"58,655,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-08-29","filed_date":"2017-08-31","scope":"insider"},{"id":4429282,"accession":"0001441557-17-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001441557-17-000020","line_url":"/filing/0001441557-17-000020","is_derivative":false,"issuer_cik":"0001187953","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001187953","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (President & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":0.30471698113207546,"price_display":"0.30","price_state":"stated","total_value":1615.0,"total_display":"1,615.00","total_whole":"1,615","shares_owned_after":58605927.0,"shares_owned_after_display":"58,605,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-05","filed_date":"2017-06-07","scope":"insider","n_lines":2},{"id":4241765,"accession":"0001441557-17-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001441557-17-000018","line_url":"/filing/0001441557-17-000018","is_derivative":false,"issuer_cik":"0001187953","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001187953","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (President & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":0.40771929824561404,"price_display":"0.41","price_state":"stated","total_value":2324.0,"total_display":"2,324.00","total_whole":"2,324","shares_owned_after":58613427.0,"shares_owned_after_display":"58,613,427","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-02","filed_date":"2017-06-05","scope":"insider","n_lines":2},{"id":5146131,"accession":"0001441557-17-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441557-17-000014","line_url":"/filing/0001441557-17-000014#line-1","is_derivative":false,"issuer_cik":"0001187953","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001187953","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (President & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":630.0,"total_display":"630.00","total_whole":"630","shares_owned_after":58616927.0,"shares_owned_after_display":"58,616,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-18","filed_date":"2017-05-19","scope":"insider"},{"id":9288706,"accession":"0001441557-17-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001441557-17-000004","line_url":"/filing/0001441557-17-000004#line-2","is_derivative":false,"issuer_cik":"0001674492","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001674492","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (President & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2935609.0,"shares_display":"2,935,609","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":293560.9,"total_display":"293,560.90","total_whole":"293,561","shares_owned_after":58618267.0,"shares_owned_after_display":"58,618,267","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-31","filed_date":"2017-01-06","scope":"insider"},{"id":4292111,"accession":"0001441557-17-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441557-17-000002","line_url":"/filing/0001441557-17-000002#line-1","is_derivative":false,"issuer_cik":"0001187953","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001187953","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (President & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2935609.0,"shares_display":"2,935,609","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":293560.9,"total_display":"293,560.90","total_whole":"293,561","shares_owned_after":62061059.0,"shares_owned_after_display":"62,061,059","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-31","filed_date":"2017-01-04","scope":"insider"},{"id":9288707,"accession":"0001441557-17-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441557-17-000004","line_url":"/filing/0001441557-17-000004#line-1","is_derivative":false,"issuer_cik":"0001674492","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001674492","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (President & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3412791.0,"shares_display":"3,412,791","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":34127.91,"total_display":"34,127.91","total_whole":"34,128","shares_owned_after":61553876.0,"shares_owned_after_display":"61,553,876","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-18","filed_date":"2017-01-06","scope":"insider"},{"id":2292661,"accession":"0001441557-16-000105","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441557-16-000105","line_url":"/filing/0001441557-16-000105#line-1","is_derivative":false,"issuer_cik":"0001187953","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","issuer_ticker":"CELZ","issuer_name_source":null,"issuer_url":"/issuer/0001187953","owner_cik":"0001674492","owner_name":"Warbington Timothy","owner_display_name":"Warbington Timothy","owner_url":"/insider/0001674492","role":"Director, Officer (President & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":64996667.0,"shares_owned_after_display":"64,996,667","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-30","filed_date":"2016-11-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":18,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001187953","name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","url":"/issuer/0001187953","role":"Director, Officer (President & CEO), Ten percent owner","n_filings":12,"first_seen":"2016-11-14","last_seen":"2023-06-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001674492","retrieved_at":"2026-08-23T05:09:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}